Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
This piece reviews index funds that pair well with Roth IRA rollovers, emphasizing broad market exposure and cost efficiency for easier long-term growth.
24,239 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
BlackRock launches a new staked Ethereum trust on Nasdaq, combining price upside with validator yields. The move mark...
Bitcoin prices linger around $71,000 as the biggest bitcoin etfs prices narrative centers on mainstream access via re...
A private AI-focused fund has surged 1,200% on hype around Anthropic and SpaceX, drawing investor demand but also gro...
SpaceX is speeding up its IPO timeline, shaking up the investing world. This guide breaks down 10 essential what-to-k...
When policymakers hint at rate moves, investors scramble to reprice risk. This guide breaks down how an evolving inte...
Retirees in 2026 are turning to three dividend ETFs to secure steady cash flow while preserving growth, with SCHD, DG...
Investors are reallocating spending toward resale, repair, and value brands. Six ETFs are positioned to ride the circ...
Newly listed THYP and BHYP tracking Hyperliquid's HYPE token post unusual first-week momentum, with sizable inflows a...
Gold can play a role in a balanced portfolio, but the best approach in 2026 depends on your goals. This guide covers ...
Cathie Wood's Ark Invest has been quietly loading up on Nvidia this week. Here are three solid reasons why her buying...
Investors often ask if selling Tesla to invest in SpaceX could pay off. This guide breaks down the reality, the optio...